Pathophysiology · Endocrine and Metabolic Disorders
Diabetes Mellitus and Pancreatic Disorders
On this page 7 sections
In 30 seconds
The pancreas keeps blood glucose in a narrow range using two hormones: Insulin Hormone that lowers blood glucose by moving it into cells and promoting storage Full entry → lowers glucose by moving it into cells and storing it, and Glucagon Hormone that raises blood glucose between meals raises it by releasing stored fuel. Diabetes mellitus is a group of disorders marked by chronic high blood glucose—type 1 from autoimmune loss of the insulin-producing beta cells, and type 2 from Insulin resistance Reduced response of cells to insulin Full entry → combined with progressive Beta-cell dysfunction Progressive failure of insulin-producing cells Full entry →. Persistently high glucose damages vessels and nerves, causing microvascular and macrovascular complications, while acute extremes can lead to diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS).
Why this matters
Diabetes and pancreatic disorders are central to nursing, medical assisting, respiratory therapy, and laboratory practice because they require ongoing glucose monitoring, patient education, and recognition of early warning signs. Understanding Hyperglycemia High blood glucose Full entry → versus Hypoglycemia Low blood glucose Full entry →—and the distinct patterns of DKA versus HHS—supports accurate reporting and timely escalation. Education emphasizes the relationship among food, activity, and glucose, foot and eye care, and when to seek urgent help. Lab values, diagnostic criteria, guidelines, and scope-of-practice vary by institution and jurisdiction and must be followed; learning pathophysiology supports assessment and reasoning but does not replace clinical training, supervision, or provider evaluation.
The college version
1. Normal function first
Glucose is the body's preferred fuel, especially for the brain. Between meals, falling blood glucose triggers the pancreatic alpha cells to release glucagon, which signals the liver to break down stored glycogen and make new glucose. After a meal, rising glucose triggers the beta cells of the pancreatic islets to release insulin. Insulin lowers blood glucose by helping glucose enter muscle and fat cells, promoting liver glycogen storage, and suppressing the liver's own glucose production.
The pancreas is a mixed gland. Its endocrine portion (the islets of Langerhans) secretes insulin, glucagon, and other regulatory hormones into the blood. Its exocrine portion secretes digestive enzymes (amylase, lipase, proteases) and bicarbonate through ducts into the small intestine. This dual role explains why the same organ can fail in two different ways—a hormone disorder (diabetes) or a digestive disorder (Pancreatitis Inflammation of the pancreas Full entry →).
2. What changes in disease
Diabetes mellitus (DM) is defined by chronic hyperglycemia (high blood glucose). Type 1 diabetes results from autoimmune destruction of beta cells, producing near-absolute insulin deficiency; it often begins in childhood or young adulthood and requires insulin for survival. Type 2 diabetes is the more common form, typically developing in adults. It begins with insulin resistance—cells respond poorly to insulin—so beta cells compensate by producing more insulin; over time beta-cell function declines and glucose rises. Risk factors include older age, family history, excess body weight, and physical inactivity, though none alone is a direct cause.
Acute emergencies reflect the extremes of fuel imbalance. Diabetic ketoacidosis (DKA) occurs mainly in type 1 diabetes, when severe insulin deficiency forces fat breakdown that produces acidic ketones—causing high glucose, acidosis, dehydration, and electrolyte loss. Hyperosmolar hyperglycemic state (HHS) occurs more often in type 2 diabetes, with very high glucose and severe dehydration but usually without significant ketosis or acidosis. Hypoglycemia (low blood glucose) is the opposite problem, most often from an imbalance between glucose-lowering medication, food intake, and activity; because the brain depends on glucose, it causes shakiness, sweating, confusion, and, if severe, loss of consciousness.
Chronic hyperglycemia damages vessels and nerves. Microvascular complications Damage to small vessels (eyes, kidneys, nerves) Full entry → affect small vessels—retinopathy (eyes), nephropathy (kidneys), and neuropathy (nerves). Macrovascular complications affect large vessels and accelerate atherosclerosis, raising the risk of heart attack, stroke, and peripheral artery disease.
Pancreatitis is inflammation of the pancreas, often triggered by gallstones or heavy alcohol use. When digestive enzymes activate inside the gland instead of in the intestine, they digest the pancreas itself, causing severe abdominal pain and inflammation. Repeated or severe pancreatitis can damage both exocrine tissue (impairing digestion) and endocrine islets (impairing insulin production).
3. Why the changes matter
Glucose imbalance is widespread, progressive, and often silent early on. The "three polys"—polyuria (excess urination), polydipsia (excess thirst), and polyphagia (excess hunger)—reflect the body shedding and replacing glucose and trying to feed energy-starved cells. Chronic hyperglycemia drives leading causes of disability: kidney failure, blindness, amputation, and cardiovascular disease. Recognizing whether a person's presentation fits type 1 (insulin-deficient, ketosis-prone) or type 2 (insulin-resistant) shapes monitoring, education, and urgency of care, though classification and management always require professional evaluation.
How it works
- A meal raises blood glucose, which signals beta cells to release insulin.
- Insulin promotes glucose uptake by muscle and fat and storage by the liver while suppressing liver glucose output.
- Blood glucose falls back toward normal, and insulin release slows.
- Between meals, falling glucose triggers glucagon, which prompts the liver to release stored glucose, keeping the level stable.
Common confusions
| Do not confuse | With | Difference |
|---|---|---|
| Type 1 diabetes | Type 2 diabetes | Type 1 is autoimmune insulin deficiency; type 2 is insulin resistance with later beta-cell decline |
| Hyperglycemia | Hypoglycemia | High versus low blood glucose, with opposite symptoms and risks |
| DKA | HHS | DKA has ketosis and acidosis (type 1); HHS has extreme hyperglycemia and dehydration without significant ketosis (type 2) |
| Exocrine pancreas | Endocrine pancreas | Exocrine secretes digestive enzymes into the gut; endocrine secretes insulin and glucagon into the blood |
Memory aids
Remember the complication targets of chronic high glucose as "N-E-R-K": Nerves, Eyes, Renal (kidneys), and (macrovascular) Heart/vessels—"glucose is like sticky syrup, gunking up the small pipes and nerves over time."
Quick review
Topic Recap
- Insulin lowers and glucagon raises blood glucose through a coordinated feeding–fasting cycle.
- Type 1 diabetes is autoimmune beta-cell loss; type 2 diabetes is insulin resistance plus beta-cell decline.
- Hyperglycemia causes the three polys and, chronically, microvascular and macrovascular damage.
- DKA and HHS are distinct acute emergencies of severe hyperglycemia, while hypoglycemia is the opposite acute risk.
- Pancreatitis damages the mixed-function pancreas, potentially impairing both digestion and insulin production.
Knowledge Check
- Which two hormones oppose each other to keep blood glucose stable, and what does each do?
- What is the core defect in type 1 versus type 2 diabetes?
- Why does DKA occur mainly in type 1 diabetes while HHS occurs more often in type 2 diabetes?
- Name the three classic "polys" of hyperglycemia and what drives them.
- How can pancreatitis lead to both digestive problems and glucose-control problems?
Answers and Rationales
- Answer: Insulin lowers glucose (cellular uptake and storage) and glucagon raises it (liver glucose release). Why: Their balance keeps glucose within a narrow range through the feeding–fasting cycle.
- Answer: Type 1 is autoimmune destruction of beta cells (near-absolute insulin deficiency); type 2 is insulin resistance with progressive beta-cell dysfunction. Why: The underlying defect determines ketosis-proneness and management approach.
- Answer: Type 1 has severe insulin deficiency, so fat is burned and ketones/acidosis result; type 2 usually retains enough insulin to suppress ketosis but develops extreme hyperglycemia and dehydration. Why: Residual insulin function shapes which emergency predominates.
- Answer: Polyuria, polydipsia, and polyphagia—driven by glucose spilling into urine (osmotic diuresis), dehydration triggering thirst, and cells starving for fuel triggering hunger. Why: These reflect the body's attempts to shed and replace glucose and feed energy-starved tissues.
- Answer: Pancreatitis damages both the exocrine tissue (reducing digestive enzymes) and the endocrine islets (reducing insulin), so digestion and glucose control can both fail. Why: The pancreas is a mixed gland with two distinct functions.

Eli explains
The same idea, in plain words
Explain it like I’m 10
Think of insulin as the key that unlocks cell doors so glucose can leave the blood and enter cells to be used or stored. In type 1 diabetes, the immune system destroys the key-making factory (the beta cells), so almost no keys exist. In type 2 diabetes, the factory still makes keys, but the doors become rusty and ignore them—that is insulin resistance—so glucose stays trapped in the bloodstream while the factory works harder and eventually tires. The comparison stops being exact because insulin does far more than "unlock doors": it also tells the liver to store glucose and stop making new glucose, and it influences fat and protein. Still, the key-and-lock picture captures why blood glucose rises when insulin is missing or ignored.
Simple Example
After a sugary snack, glucose floods the blood; insulin opens the doors of muscle and liver cells so the glucose can go inside, bringing the blood level back down—like ushers clearing a crowded hallway into seats.
Worked example
- Predisposing factors or causes: Genetic predisposition and autoimmune triggers (type 1), or excess body weight, inactivity, and aging (type 2), set the stage for beta-cell loss or insulin resistance.
- Initial physiologic change: Insulin secretion falls (type 1) or insulin resistance develops (type 2), so glucose clearance from the blood is impaired.
- Compensation or adaptation: Beta cells increase insulin output to overcome resistance (type 2); the kidneys initially excrete excess glucose, producing polyuria and compensatory thirst.
- Progression or decompensation: Beta-cell function declines, hyperglycemia worsens, and the body may turn to fat breakdown (ketones) or develop profound dehydration as glucose-lowering capacity fails.
- Broad manifestations and possible complications: The three polys, weight change, fatigue, and blurred vision, followed over time by microvascular (retina, kidney, nerve) and macrovascular (heart, brain, limbs) complications and, acutely, DKA or HHS.
Key takeaways
- High yield: Type 1 diabetes is autoimmune beta-cell destruction (near-absolute insulin deficiency); type 2 diabetes is insulin resistance plus progressive beta-cell dysfunction.
- Insulin lowers glucose; glucagon raises it—they are the opposing hormones of glucose homeostasis.
- The classic symptoms of hyperglycemia are the "three polys": polyuria, polydipsia, and polyphagia.
- DKA (ketosis and acidosis, typical of type 1) and HHS (severe hyperglycemia and dehydration, typical of type 2) are distinct acute emergencies.
- Hypoglycemia affects the brain first (shakiness, sweating, confusion) because the brain depends on glucose.
- Microvascular complications are retinopathy, nephropathy, and neuropathy; macrovascular complications accelerate atherosclerosis (heart attack, stroke, peripheral artery disease).
- The pancreas is both endocrine (islet hormones) and exocrine (digestive enzymes), so pancreatitis can impair both glucose control and digestion.
Study tools & related lessonsYou’ll learn to · Key vocabulary · Related
You’ll learn to
- Explain glucose homeostasis and the opposing roles of insulin and glucagon.
- Describe the endocrine and exocrine functions of the pancreas.
- Contrast type 1 and type 2 diabetes mellitus in terms of insulin resistance, beta-cell dysfunction, and typical onset.
- Define hyperglycemia and hypoglycemia and connect them to the concepts of DKA and HHS.
- Summarize the microvascular and macrovascular complications of chronic hyperglycemia and the pathophysiology of pancreatitis.
Key vocabulary
- Insulin
- Hormone that lowers blood glucose by moving it into cells and promoting storage
- Glucagon
- Hormone that raises blood glucose between meals
- Insulin resistance
- Reduced response of cells to insulin
- Beta-cell dysfunction
- Progressive failure of insulin-producing cells
- Hyperglycemia
- High blood glucose
- Hypoglycemia
- Low blood glucose
- DKA (diabetic ketoacidosis)
- Acidosis from fat breakdown during severe insulin deficiency
- HHS (hyperosmolar hyperglycemic state)
- Severe hyperglycemia with dehydration, usually without ketosis
- Microvascular complications
- Damage to small vessels (eyes, kidneys, nerves)
- Pancreatitis
- Inflammation of the pancreas
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.
